Crawford Investment Counsel’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2M Buy
111,876
+2,044
+2% +$195K 0.21% 94
2025
Q4
$8.91M Buy
109,832
+2,130
+2% +$183K 0.15% 115
2025
Q3
$9.43M Sell
107,702
-3,270
-3% -$292K 0.16% 112
2025
Q2
$9.22M Buy
110,972
+2,010
+2% +$168K 0.16% 112
2025
Q1
$9.14M Sell
108,962
-460
-0.4% -$42.8K 0.16% 114
2024
Q4
$10.1M Buy
109,422
+1,863
+2% +$179K 0.18% 105
2024
Q3
$9.99M Sell
107,559
-2,595
-2% -$225K 0.17% 105
2024
Q2
$9.06M Sell
110,154
-17,350
-14% -$1.27M 0.17% 100
2024
Q1
$8.46M Sell
127,504
-2,340
-2% -$144K 0.16% 104
2023
Q4
$7.37M Buy
129,844
+10,340
+9% +$542K 0.15% 107
2023
Q3
$6.51M Buy
119,504
+11,379
+11% +$674K 0.14% 111
2023
Q2
$7.27M Sell
108,125
-1,905
-2% -$116K 0.15% 105
2023
Q1
$5.66M Buy
110,030
+14,357
+15% +$697K 0.12% 118
2022
Q4
$4.4M Buy
95,673
+6,595
+7% +$309K 0.09% 128
2022
Q3
$4.51M Buy
89,078
+1,560
+2% +$78K 0.11% 127
2022
Q2
$3.99M Buy
+87,518
New +$3.91M 0.09% 135

Other funds holding LMAT

Crawford Investment Counsel's LMAT Position: Q1 2026 in Review

Crawford Investment Counsel increased its LeMaitre Vascular (LMAT) stake by 1.9% in Q1 2026, buying an estimated $195K and bringing the position to 111,876 shares worth $12.2M. The position accounts for 0.21% of the portfolio, ranked #94.

Crawford Investment Counsel first reported a position in LMAT in Q2 2022 and has held it in 16 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Crawford Investment Counsel held 111,876 shares of LeMaitre Vascular worth $12.2M as of Q1 2026.
  • Crawford Investment Counsel bought 2,044 LeMaitre Vascular shares in Q1 2026, an estimated $195K.
  • LeMaitre Vascular made up 0.21% of Crawford Investment Counsel's portfolio in Q1 2026, its #94 holding.
  • Crawford Investment Counsel first reported a position in LeMaitre Vascular in Q2 2022 and has held it in 16 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.